LJ2-71629-25064
2 vaccinations
1 coded response
26 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 314 / GA
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-01-07
Registered in v-safe
-
2021-01-07
Dose 1 — Moderna
- 2021-01-07
-
2021-01-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-08
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-21
- 2021-01-21
- 2021-01-26
- 2021-01-28
- 2021-01-29
-
2021-02-04
Dose 2 — Moderna
- 2021-02-04
-
2021-02-05
Survey response — days 1–6 daily, dose 2MedDRA: Hyperhidrosis — Feeling: Good · Site: Pain · Fever · Chills, Fatigue or tiredness, NauseaFree text: SweatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-05-06
- 2021-08-05
- 2022-02-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Moderna | |
| 2 | 2021-02-04 | Moderna |
Call center
1 call center case
1 unsuccessful
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Sweating
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release